Paul T Quinlan Cyma Bay Therapeutics, Inc. (CBAY) insider trading activity

Paul T Quinlan is General Counsel of CymaBay Therapeutics, Inc.. Currently has a direct ownership of 0 shares of CBAY, which is worth approximately $0. The most recent transaction as insider was on Mar 22, 2024, when has been sold 70,262 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Paul T Quinlan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 22 2024	SELL Sale (or disposition) back to the issuer	-	70,262 Reduced 100.0%	0 Common Stock
Mar 13 2024	BUY Exercise of conversion of derivative security	$329,991 $7.89 p/Share	41,824 Added 37.31%	70,262 Common Stock
Jan 24 2024	BUY Grant, award, or other acquisition	-	28,438 Added 50.0%	28,438 Common Stock
Jan 16 2024	SELL Open market or private sale	$117,899 $23.58 p/Share	5,000 Reduced 100.0%	0 Common Stock
Jan 16 2024	BUY Exercise of conversion of derivative security	$14,700 $2.94 p/Share	5,000 Added 50.0%	5,000 Common Stock
Dec 15 2023	SELL Open market or private sale	$109,900 $21.98 p/Share	5,000 Reduced 100.0%	0 Common Stock
Dec 15 2023	BUY Exercise of conversion of derivative security	$14,700 $2.94 p/Share	5,000 Added 50.0%	5,000 Common Stock
Nov 15 2023	SELL Open market or private sale	$86,900 $17.38 p/Share	5,000 Reduced 100.0%	0 Common Stock
Nov 15 2023	BUY Exercise of conversion of derivative security	$14,700 $2.94 p/Share	5,000 Added 50.0%	5,000 Common Stock
Oct 16 2023	SELL Open market or private sale	$68,800 $13.76 p/Share	5,000 Reduced 100.0%	0 Common Stock
Oct 16 2023	BUY Exercise of conversion of derivative security	$14,700 $2.94 p/Share	5,000 Added 50.0%	5,000 Common Stock
Sep 15 2023	SELL Open market or private sale	$894,110 $16.87 p/Share	53,000 Reduced 100.0%	0 Common Stock
Sep 15 2023	BUY Exercise of conversion of derivative security	$155,820 $2.94 p/Share	53,000 Added 68.83%	24,000 Common Stock
Aug 15 2023	SELL Open market or private sale	$59,550 $11.91 p/Share	5,000 Reduced 100.0%	0 Common Stock
Aug 15 2023	BUY Exercise of conversion of derivative security	$14,700 $2.94 p/Share	5,000 Added 50.0%	5,000 Common Stock
Jul 14 2023	SELL Open market or private sale	$59,050 $11.81 p/Share	5,000 Reduced 100.0%	0 Common Stock
Jul 14 2023	BUY Exercise of conversion of derivative security	$14,700 $2.94 p/Share	5,000 Added 50.0%	5,000 Common Stock
Jun 30 2023	SELL Open market or private sale	$50,250 $10.05 p/Share	5,000 Reduced 100.0%	0 Common Stock
Jun 30 2023	BUY Exercise of conversion of derivative security	$14,700 $2.94 p/Share	5,000 Added 50.0%	5,000 Common Stock
May 15 2023	SELL Open market or private sale	$51,849 $10.37 p/Share	5,000 Reduced 100.0%	0 Common Stock
May 15 2023	BUY Exercise of conversion of derivative security	$14,700 $2.94 p/Share	5,000 Added 50.0%	5,000 Common Stock

PTQ

Paul T Quinlan

General Counsel

Newark, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CBAY shares.

Notify only if

Value

Insider Trading

Get notified when an Cyma Bay Therapeutics, Inc. insider buys or sells CBAY shares.

Notify only if

Operation

Value

Type

News

Receive news related to CymaBay Therapeutics, Inc.

Track Activities on CBAY

Account